Defining the Cooperative Genetic Changes That Temporally Drive Alveolar Rhabdomyosarcoma
Open Access
- 1 December 2008
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 68 (23), 9583-9588
- https://doi.org/10.1158/0008-5472.can-07-6178
Abstract
Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma of childhood and adolescence. Despite advances in therapy, patients with a histologic variant of RMS known as alveolar (aRMS) have a 5-year survival rate of MYCN, stabilization of telomeres, and most characteristically, reciprocal translocation of loci involving the PAX and FKHR genes, generating the PAX7-FKHR or PAX3-FKHR fusion proteins. We previously showed that PAX3-FKHR expression in primary human myoblasts, cells that can give rise to RMS, cooperated with loss of p16INK4A to promote extended proliferation. To better understand the genetic events required for aRMS formation, we then stepwise converted these cells to their transformed counterpart. PAX3-FKHR, the catalytic unit of telomerase hTERT, and MycN, in cooperation with down-regulation of p16INK4A/p14ARF expression, were necessary and sufficient to convert normal human myoblasts into tumorigenic cells that gave rise to aRMS tumors. However, the order of expression of these transgenes was critical, as only those cells expressing PAX3-FKHR early could form tumors. We therefore suggest that the translocation of PAX3 to FKHR drives proliferation of myoblasts, and a selection for loss of p16INK4A/p14ARF. These early steps, coupled with MycN amplification and telomere stabilization, then drive the cells to a fully tumorigenic state. [Cancer Res 2008;68(23):9583–8]Other Versions
This publication has 21 references indexed in Scilit:
- Epigenetic Down-Regulation of ARF Expression Is a Selection Step in Immortalization of Human Fibroblasts by c-MycMolecular Cancer Research, 2007
- Analysis of the transforming and growth suppressive activities of the PAX3-FKHR oncoproteinOncogene, 2004
- Soft tissue sarcomas of childhoodCancer Treatment Reviews, 2004
- A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cellsNature, 2004
- PAX3-FKHR and PAX7-FKHR Gene Fusions Are Prognostic Indicators in Alveolar Rhabdomyosarcoma: A Report From the Children’s Oncology GroupJournal of Clinical Oncology, 2002
- Molecular pathogenesis of rhabdomyosarcoma.Cancer Biology & Therapy, 2002
- cDNA microarrays detect activation of a myogenic transcription program by thePAX3-FKHRfusion oncogeneProceedings of the National Academy of Sciences of the United States of America, 1999
- Creation of human tumour cells with defined genetic elementsNature, 1999
- Fusion of PAX3 to a member of the forkhead family of transcription factors in human alveolar rhabdomyosarcoma.1993
- Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcomaNature Genetics, 1993